Michael Agostino, PhD
Senior Bioinformatics Analyst, Pfizer, Inc.
Mike Agostino has a BS in biology from the University of Massachusetts, Dartmouth and a PhD in molecular biology from Roswell Park Cancer Institute, affiliated with the State University of New York at Buffalo. He has eleven years of bench work experience involving genetic engineering and the development of molecular assays. This work includes studying the structure and evolution of sea urchin histone genes, the design and creation of synthetic genes, and the development of an E. coli blue-white assay for HIV protease activity. For the past twenty-six years, Agostino has been in the pharmaceutical industry at Glaxo and Pfizer, specializing in bioinformatics sequence analysis. During this time, he has analyzed genes and proteins and provided education and software support for scientists. Agostino has authored a textbook on sequence analysis.
- PhD State University of New York, Buffalo
Courses with Michael Agostino
Spring term 2018
With breakthroughs in biotechnology such as high-throughput and inexpensive DNA sequencing, we are collecting vast amounts of data that will be analyzed for years to come. The details of this data reveal basic information such as gene and protein structures, and may lead us to major discoveries like gene-disease associations.